Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Human arteries engineered in vitro.

J Andrew McKee1, Soma S R Banik, Matthew J Boyer

  • 1Department of Anesthesiology and Department of Biomedical Engineering, Duke University Medical Center, Durham, NC 27710, USA.

EMBO Reports
|May 31, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Outcomes of 5- Versus 10-Fraction Radiation Therapy for Hepatocellular Carcinoma at a Veteran Affairs Hospital.

International journal of radiation oncology, biology, physics·2026
Same author

Engineering function in lung biology: integrating imaging, regenerative constructs, and functional biodesign.

American journal of physiology. Lung cellular and molecular physiology·2026
Same author

Editorial Expression of Concern: Creation of human tumour cells with defined genetic elements.

Nature·2026
Same author

Profiling KRAS mutations in whole blood by error-corrected maximum depth sequencing.

NPJ precision oncology·2026
Same author

Loss of inducible nitric oxide synthase promotes Kras/Pten-driven lung tumorigenesis.

Frontiers in cell and developmental biology·2026
Same author

Vascular Endothelial Growth Factor-D Improves Lung Vascular Integrity During Acute Lung Injury.

Circulation research·2026
Same journal

Gata3 dosage governs primitive endoderm versus trophectoderm specification in embryonic stem cells.

EMBO reports·2026
Same journal

PARG inhibition reduces ssDNA levels and limits RPA loading upon replication fork collapse.

EMBO reports·2026
Same journal

Academic independence?

EMBO reports·2026
Same journal

GATOR1 signaling defects promote astrocytic metabolic rewiring and excitatory neurotransmitter cycling.

EMBO reports·2026
Same journal

Lipid droplets promote aberrant liquid-liquid phase separation of alpha-synuclein impairing energy homeostasis.

EMBO reports·2026
Same journal

Publisher Correction: Collagen VI is a fibrosis-associated signal disrupting muscle regeneration across distinct human myopathies.

EMBO reports·2026
See all related articles

Researchers engineered robust small-calibre arteries for bypass surgery using human smooth muscle cells (SMCs) modified with human telomerase reverse transcriptase (hTERT). This overcomes the limited proliferation of SMCs, enabling the creation of clinically valuable vascular grafts.

Area of Science:

  • Biomedical Engineering
  • Vascular Tissue Engineering
  • Cell Biology

Background:

  • Developing small-calibre arteries for bypass surgery is challenging.
  • Limited proliferation of non-neonatal smooth muscle cells (SMCs) hinders vascular tissue engineering.

Purpose of the Study:

  • To overcome SMC proliferation limitations for engineering vascular grafts.
  • To assess the feasibility of using hTERT-modified SMCs in tissue-engineered arteries.

Main Methods:

  • Introduced human telomerase reverse transcriptase (hTERT) into human SMCs.
  • Cultured and characterized hTERT-modified SMCs for extended lifespan and retained function.
  • Engineered mechanically robust small-calibre arteries using these modified SMCs.

Related Experiment Videos

Main Results:

  • hTERT-modified SMCs exhibited significantly extended proliferative capacity beyond normal lifespan.
  • Modified SMCs maintained characteristics of normal control SMCs.
  • Successfully engineered mechanically robust human vascular grafts.

Conclusions:

  • Ectopic hTERT expression overcomes proliferative limitations in human SMCs.
  • This approach enables the engineering of clinically relevant vascular tissues.
  • This represents a significant advancement towards bypass surgery solutions.